Showing 1721-1730 of 2494 results for "".
- Focus A-Eye to Launch Inaugural AI Summit Advancing the Future of Ophthalmologyhttps://modernod.com/news/focus-a-eye-to-launch-inaugural-ai-summit-advancing-the-future-of-ophthalmology/2486795/Focus A-Eye, a specialized medical education and innovation forum dedicated to advancing the application of AI in ophthalmology, has announced the launch of its inaugural Focus A-Eye Summit, set to take place on Saturday, May 2, 2026, in Denver, Colorado.
- American Academy of Optometry Announces 2026 Retina Summit in Indianapolishttps://modernod.com/news/american-academy-of-optometry-announces-2026-retina-summit-in-indianapolis/2486018/The American Academy of Optometry has announced the 2026 Retina Summit, a 1-day continuing education program focused on advancing clinical knowledge and patient care in retinal disease. The event will take place Saturday, April 18, 2026, at the Indianapolis Marriott
- Registration Now Open for Neuro-Optometric Rehabilitation Association (NORA) 2025 Conferencehttps://modernod.com/news/registration-now-open-for-neuro-optometric-rehabilitation-association-nora-2025-conference/2482791/The Neuro-Optometric Rehabilitation Association, International (NORA), which advocates for advancing neurovisual rehabilitation, has opened registration for its 35th Annual Conference, taking place September 18–21, 2025, at the Hilton Denver City Center in Denver, Colorado. N
- Opus Genetics Announces Presentation of OPGX-LCA5 Gene Therapy Data at ARVOhttps://modernod.com/news/opus-genetics-announces-presentation-of-opgx-lca5-gene-therapy-data-at-arvo/2482782/Opus Genetics announced 1-year results from adult patients treated in the ongoing phase 1/2 Study of its lead gene therapy candidate OPGx-LCA5. These results were presented at the 2025 annual meeting of the Association for Research in Vision and Ophthalmology (ARVO), taking place May 4
- Sydnexis Announces Three Abstracts Accepted for Poster Presentations at ARVOhttps://modernod.com/news/sydnexis-announces-three-abstracts-accepted-for-poster-presentations-at-arvo/2482780/Sydnexis announced that three abstracts have been accepted for poster presentations at the upcoming Association for Research in Vision and Ophthalmology (ARVO) 2025 meeting taking place from May 4 to 8 in Salt Lake City. These posters present clinical data related to the STAR Study
- Sight Sciences Launches OMNI Edge Surgical System at ASCRShttps://modernod.com/news/sight-sciences-to-debut-omni-edge-surgical-system-at-ascrs/2482748/Sight Sciences announced the expansion of the OMNI product family by launching the OMNI Edge Surgical System. The new technology will debut at the 2025 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, taking place April 25–27 in Los Angeles.<
- Johnson & Johnson to Showcase Tecnis Odyssey IOL and Present New Research at AAO 2024https://modernod.com/news/johnson-johnson-to-showcase-tecnis-odyssey-iol-and-present-new-research-at-aao-2024/2482501/Johnson & Johnson will highlight its latest innovations in eye health during the 2024 American Academy of Ophthalmology (AAO) annual meeting, taking place from October 18-21 in Chicago. Among the company's spotlight advancements is the Tecnis Odyssey IOL, a new presbyopia-correcting IOL t
- Bausch + Lomb Announces New Data and Events at the 2024 AAO Annual Meeting in Chicagohttps://modernod.com/news/bausch-lomb-announces-new-data-and-events-at-the-2024-aao-annual-meeting-in-chicago/2482493/Bausch + Lomb announced its upcoming presentations and educational events at the American Academy of Ophthalmology (AAO) annual meeting, taking place in Chicago from October 18-21, 2024. The company will showcase new scientific data on its eye health products and technologies, incl
- Centricity Vision Unveils Enhancements to ZEPTOLink IOL Positioning System at AAO 2024https://modernod.com/news/centricity-vision-unveils-enhancements-to-zeptolink-iol-positioning-system-at-aao-2024/2482487/Centricity Vision announced platform enhancements for its ZEPTOLink IOL Positioning System designed to reduce treatment time by up to 60%. The enhancements will be highlighted at the American Academy of Ophthalmology (AAO) annual meeting, taking place from October 18-21, 2024, in Chicago.
- Aura Biosciences to Present Phase 2 Data on Belzupacap Sarotalocan for Choroidal Melanoma at Retina Society Annual Meetinghttps://modernod.com/news/aura-biosciences-to-present-phase-2-data-on-belzupacap-sarotalocan-for-choroidal-melanoma-at-retina-society-annual-meeting/2482412/Aura Biosciences announced that final data from its phase 2 study on the suprachoroidal administration of belzupacap sarotalocan (bel-sar) for treating small choroidal melanoma and indeterminate lesions will be presented at the Retina Society Annual Meeting. The event will take place from Septemb